Report Details-
Asia-Pacific Automated Cell Cultures Market, By Product (Consumables, Instruments), Type (Infinite Cell Line Cultures, Finite Cell Line Cultures), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, Others), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Market Analysis and Insights: Asia-Pacific Automated Cell Cultures Market
Asia-Pacific automated cell cultures market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.8% in the forecast period of 2021 to 2028 and is expected to reach USD 5,733.68 million by 2028. Increasing demand of cell culture technology in vaccine production, and wide acceptance of cell culture techniques in various applications are the major drivers which propelled the demand of the market in the forecast period.
Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors.
Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.
Automated Cell Cultures Market Country Level Analysis
The automated cell cultures market is analyzed and market size information is provided on the basis of product, type, application, and end user as referenced above.
The countries covered in the market report are the Japan, China, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.
Biotech companies segment in Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 due to wide acceptance of cell culture techniques in various applications.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Asia-Pacific Automated Cell Cultures Market Scope and Market Size
Automated cell cultures market is segmented on the basis of product, type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of product, the Asia-Pacific automated cell cultures market is segmented into consumables, and instruments. The instruments is further segmented into supporting equipment, bioreactors, and storage equipment. In 2021, the consumables segment is expected to dominate the market due to increase in lab efficiency for better economical results.
On the basis of type, the Asia-Pacific automated cell cultures market is segmented into infinite cell line cultures and finite cell line cultures. In 2021, the infinite cell line cultures segment is expected to dominate the market due to wide acceptance of cell culture techniques in various applications.
On the basis of application, the Asia-Pacific automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccines, and others. In 2021, the drug development segment is dominating the market due to technological advancements in cell culture technology systems.
Access Full Report:- https://www.databridgemarketresearch.com/reports/asia-pacific-automated-cell-cultures-market
Competitive Landscape and Automated Cell Cultures Market Share Analysis
Automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to automated cell cultures market.
The major companies operating in the automated cell cultures market are Lonza, Eppendorf AG, Thermo Fisher Scientific Inc., Merck KGaA, Tecan, BD, Corning Incorporated among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the automated cell cultures market.
For instance,
In May 2021, PromoCell GmbH announced the launch of the Air Liquid Interface Culture System in combination with pre-screened human bronchial epithelial cells. This will enable the company creation of a reproducible human 3D airway model with a stable and predictable epithelial barrier function
In April 2021, Thermo Fisher Scientific Inc entered into a definitive agreement with PPD, Inc. According to the agreement, the company will acquire PPD, Inc. for USD 47.50/share of a total worth of USD 17.4 Billion. The agreement will help the company to develop new competencies and resources
In April 2021, BioSpherix Ltd announced that its partnership with Phase Holographic Imaging (PHI) has helped yield Holo Monitor Analyzer. The company further added that recently, EU-funded Centre for Innovative Medicine bought its first Holo Monitor analyzer for use in the center’s incubator system. It has helped the company to expand its product portfolio and earn more revenue
Request Access for Sample Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-automated-cell-cultures-market
Major TOC of the Report
· INTRODUCTION
· MARKET SEGMENTATION
· MARKET OVERVIEW
· EXECUTIVE SUMMARY
Get TOC of the Report:- https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-automated-cell-cultures-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Browse Related Reports@
#Healthcare, #Asia-Pacific Automated Cell Cultures Market, #Asia-Pacific Automated Cell Cultures Market Size, #Asia-Pacific Automated Cell Cultures Market Share,
Comments